PHP
ARAY icon

Parkman Healthcare Partners’s Accuray ARAY Stock Holding History

Parkman Healthcare Partners’s Portfolio ARAY Stock Details ARAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-884,578
Closed -$343K – 81
2026
Q1 		$343K Buy
884,578
+32,566
+4% +$20.1K 0.04% 89
2025
Q4 		$703K Buy
+852,012
New +$1.06M 0.07% 94

Other funds holding ARAY

TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $118M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Parkman Healthcare Partners's ARAY Position: Q2 2026 in Review

Parkman Healthcare Partners sold out of Accuray (ARAY) in Q2 2026, closing a stake of 884,578 shares — an estimated $343K sold.

Parkman Healthcare Partners first reported a position in ARAY in Q4 2025 and held it in 2 quarters. The position peaked at $703K in Q4 2025. 111 funds tracked by Wall St. Rank hold ARAY as of Q2 2026.

  • Parkman Healthcare Partners reported no remaining Accuray position as of Q2 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 884,578 Accuray shares in Q2 2026, an estimated $343K.
  • Parkman Healthcare Partners first reported a position in Accuray in Q4 2025 and held it in 2 quarters.
  • Parkman Healthcare Partners's Accuray position peaked at $703K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Accuray as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.